Timothy syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A multicentre study of patients with Timothy syndrome.
|
28371864 |
2018 |
Timothy syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Emerging therapeutic targets in the short QT syndrome.
|
29697308 |
2018 |
Timothy syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Through expanded whole exome sequencing, we identified a novel genetic substrate for TS, p.Ile1166Thr-CACNA1C.
|
25260352 |
2015 |
Timothy syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Through whole exome sequencing and expanded cohort screening, we identified a novel genetic substrate p.Arg518Cys/His-CACNA1C, in patients with a complex phenotype including LQTS, HCM, and congenital heart defects annotated as cardiac-only Timothy syndrome.
|
26253506 |
2015 |
Timothy syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Through whole exome sequencing and expanded cohort screening, we identified a novel genetic substrate p.Arg518Cys/His-CACNA1C, in patients with a complex phenotype including LQTS, HCM, and congenital heart defects annotated as cardiac-only Timothy syndrome.
|
26253506 |
2015 |
Timothy syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
This study aimed to elucidate the frequency of CACNA1C mutations in patients with long QT syndrome (LQTS), except those with Timothy syndrome and investigate phenotypic variants.
|
24728418 |
2014 |
Timothy syndrome
|
1.000 |
GermlineCausalMutation
|
disease |
ORPHANET |
Genotype- and phenotype-guided management of congenital long QT syndrome.
|
24093767 |
2013 |
Timothy syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations.
|
15863612 |
2005 |
Timothy syndrome
|
1.000 |
Biomarker
|
disease |
CTD_human |
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
|
15454078 |
2004 |
Timothy syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
|
15454078 |
2004 |
Timothy syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism.
|
15454078 |
2004 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
Genome-wide association study identifies 30 loci associated with bipolar disorder.
|
31043756 |
2019 |
Major Depressive Disorder
|
0.700 |
Biomarker
|
disease |
CTD_human |
Single-nucleotide polymorphisms (SNPs) in CACNA1C, the α1C subunit of the voltage-gated L-type calcium channel Ca<sub>v</sub>1.2, rank among the most consistent and replicable genetics findings in psychiatry and have been associated with schizophrenia, bipolar disorder and major depression.
|
28696432 |
2018 |
Brugada Syndrome 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A multicentre study of patients with Timothy syndrome.
|
28371864 |
2018 |
Brugada Syndrome 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Emerging therapeutic targets in the short QT syndrome.
|
29697308 |
2018 |
Brugada Syndrome 3
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Identification and Functional Characterization of a Novel CACNA1C-Mediated Cardiac Disorder Characterized by Prolonged QT Intervals With Hypertrophic Cardiomyopathy, Congenital Heart Defects, and Sudden Cardiac Death.
|
26253506 |
2015 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Our findings implicate abnormal perigenual and hippocampal activation as a promising intermediate phenotype for psychiatric disease and suggest a pathophysiologic mechanism conferred by a CACNA1C variant being implicated in risk for symptom dimensions shared among bipolar disorder, major depression, and schizophrenia.
|
24411473 |
2014 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
The variants at ANK3 and CACNA1C previously known to be associated with BP were not in linkage disequilibrium with either of the two variants that we identified and these are therefore independent of the previous haplotypes implicated by genome-wide association.
|
24716743 |
2014 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Genotyping of five genome-wide significant variants identified for BD (in CACNA1C, ANK3, and ODZ4) was performed in 673 BPD cases and 748 controls.
|
25304227 |
2014 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
In treatment of BD with calcium channel blocking drugs, we would predict better response in patients without the risk allele, because they have increased CACNA1C expression.
|
23979604 |
2014 |
Bipolar Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
The variant at rs1006737 in the L-type voltage-gated calcium channel (alpha 1c subunit) CACNA1C gene is reliably associated with both bipolar disorder and schizophrenia.
|
25290268 |
2014 |
Major Depressive Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Our findings implicate abnormal perigenual and hippocampal activation as a promising intermediate phenotype for psychiatric disease and suggest a pathophysiologic mechanism conferred by a CACNA1C variant being implicated in risk for symptom dimensions shared among bipolar disorder, major depression, and schizophrenia.
|
24411473 |
2014 |
Major Depressive Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Since CACNA1C variants have been associated repeatedly with psychosis at a genome-wide level, and preclinical data provide convergent evidence for the relevance of the CACNA1C gene for hippocampal and frontolimbic plasticity and adaptive regulation of stress, our data suggest a potential pathophysiological mechanism conferred by CACNA1C variants that may mediate risk for symptom dimensions shared among bipolar disorder, major depression, and schizophrenia.
|
24642287 |
2014 |
Major Depressive Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Our findings support CACNA1C being a risk gene for both schizophrenia and major depressive disorder in the Han Chinese population.
|
24262814 |
2014 |
Major Depressive Disorder
|
0.700 |
Biomarker
|
disease |
PSYGENET |
Recent genome-wide association studies have pointed to single-nucleotide polymorphisms (SNPs) in genes encoding the neuronal calcium channel CaV1.2 (CACNA1C; rs1006737) and the presynaptic active zone protein Piccolo (PCLO; rs2522833) as risk factors for affective disorders, particularly major depression.
|
24643163 |
2014 |